One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Hydroxychloroquine tablets Saltwater fish chloroquine compatible with meteoplex At risk lifetime dosage of hydroxychloroquine Malaria treatment chloroquine how many daily The 2016 American Academy of Ophthalmology Hydroxychloroquine Dosing Guidelines For Short, Obese Patients. Browning DJ1, Easterbrook M2, Lee C3. Author information 1Department of Ophthalmology, Charlotte Eye, Ear, Nose and Throat Associates, P. A. Charlotte, North Carolina. Mar 01, 2011 The new guidelines recommend 10-2 automated perimetry, plus at least one of SD-OCT, FAF, or mfERG if they are available. These tests should be performed at baseline and at each subsequent evaluation. Other tests may be considered as well, but are generally insufficiently sensitive to detect early evidence of hydroxychloroquine toxicity. The previous AAO guideline recommended screening every 12 months. Of course the aim is avoid drug related retinal toxicity, which on ophthalmic examination, appears as the classic Bull’s eye change affecting the macula. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Aao guidelines for plaquenil Plaquenil Pertinent Questions -, New Screening Guidelines for Hydroxychloroquine Toxicity Plaquenil and foot pain Jun 14, 2017 Do you know the current screening recommendations for patients on Plaquenil? Which tests should you choose and when? Risk factors for toxicity are high dose, long duration, renal disease and tamoxifen. If you are coming to the OA July Scientific Meeting July 29th Red Hill, you will hear more about Plaquenil toxicity. AAO Guidelines for Chloroquine Screening. My Take on New Ocular Screening Guidelines for Plaquenil.. What Is Plaquenil? - American Academy of Ophthalmology. Plaquenil toxicity isn’t even in the top 10, or the top 100” if you’re looking at incidence, he said. “It’s a pretty rare thing.” Nevertheless, he urged doctors to master the Academy’s new guidelines, because the effects from chloroquine and hydroxychloroquine, when they do occur, are severe and often irreversible. Current AAO guidelines do not specifically address dosing in obese patients. AAO also recommends baseline screening for retinal toxicity and annual screening beginning after 5 years of use or sooner if major risk factors are present Marmor AAO 2016. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria.